Abstract
Since the first edition of this textbook, the nomenclature has been revised after an extensive international work within the Vitiligo Global Issues Consensus Conference (VGICC). Vitiligo/nonsegmental vitiligo (NSV) is a consensus umbrella term for all forms of generalized vitiligo. It is an acquired chronic pigmentation disorder characterized by white patches, often symmetrical, which usually increases in size with time, corresponding to a substantial loss of functioning epidermal and sometimes hair follicle melanocytes. The two other subsets of vitiligo defined by the international consensus are segmental vitiligo and unclassified/undetermined vitiligo which correspond to focal disease and rare variants. A series of hypopigmented disorders may masquerade as vitiligo, and some of them need to be ruled out by specific procedures including a skin biopsy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Taïeb A, Picardo M, VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20:27–35.
Koga M. Vitiligo: a new classification and therapy. Br J Dermatol. 1977;97:255–61.
Gauthier Y, Cario-Andre M, Taieb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res. 2003;16:322–32.
Mulekar SV, Al Issa A, Asaad M, et al. Mixed vitiligo. J Cutan Med Surg. 2006;10:104–7.
Ezzedine K, Amazan E, Séneschal J, Cario-André M, Léauté-Labrèze C, Vergier B, Boralevi F, Taieb A. Follicular vitiligo: a new form of vitiligo. Pigment Cell Melanoma Res. 2012;25:527–9.
Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, Goh BK, Anbar T, Silva de Castro C, Lee AY, Parsad D, van Geel N, Le Poole IC, Oiso N, Benzekri L, Spritz R, Gauthier Y, Hann SK, Picardo M, Taieb A. Vitiligo Global Issue Consensus Conference Panelists. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012;25:E1–13.
Ezzedine K, Mahé A, van Geel N, Cardot-Leccia N, Gauthier Y, Descamps V, Al Issa A, Ly F, Chosidow O, Taïeb A, Passeron T. Hypochromic vitiligo: delineation of a new entity. Br J Dermatol. 2015;172:716–21.
Gan EY, Cario-André M, Pain C, Goussot JF, Taïeb A, Seneschal J, Ezzedine K. Follicular vitiligo: a report of 8 cases. J Am Acad Dermatol. 2016;74:1178–84.
Berger TG, Kiesewetter F, Maczek C, et al. Psoriasis confined strictly to vitiligo areas--a Koebner-like phenomenon? J Eur Acad Dermatol Venereol. 2006;20:178–83.
Singh ZN, Tretiakova MS, Shea CR, Petronic-Rosic VM. Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo. Mod Pathol. 2006;19:1255–60.
Hartmann A, Bedenk C, Keikavoussi P, et al. Vitiligo and melanoma-associated hypopigmentation (MAH):shared and discriminative features. J Dtsch Dermatol Ges. 2008;6:1053–9.
Gogas H, Ioannovich J, Dafni U, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med. 2006;354:709–18.
Thoma W, Krämer HJ, Mayser P. Pityriasis versicolor alba. J Eur Acad Dermatol Venereol. 2005;19:147–52.
Guillet G, Helenon R, Gauthier Y, et al. Progressive macular hypomelanosis of the trunk: primary acquired hypopigmentation. J Cutan Pathol. 1988;15:286–9.
Relyveld GN, Dingemans KP, Menke HE, et al. Ultrastructural findings in progressive macular hypomelanosis indicate decreased melanin production. J Eur Acad Dermatol Venereol. 2008;22:568–74.
Westerhof W, Relyveld GN, Kingswijk MM, et al. Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosis. Arch Dermatol. 2004;140:210–4.
Oplatek A, Brown K, Sen S, et al. Long-term follow-up of patients treated for toxic epidermal necrolysis. J Burn Care Res. 2006;27:26–33.
Smith DA, Burgdorf WH. Universal cutaneous depigmentation following phenytoin-induced toxic epidermal necrolysis. J Am Acad Dermatol. 1984;10:106–9.
Boissy RE, Manga P. On the etiology of contact/occupational vitiligo. Pigment Cell Res. 2004;17:208–14.
Cario-André M, Ardilouze L, Pain C, et al. Imatinib mesilate inhibits melanogenesis in vitro. Br J Dermatol. 2006;155:493–4.
Mashiah J, Brenner S. Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod. Clin Exp Dermatol. 2008;33:74–6.
Hann SK, Lee HJ. Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol. 1996;35:671–4.
Lee HS, Chun YS, Hann SK. Nevus depigmentosus: clinical features and histopathologic characteristics in 67 patients. J Am Acad Dermatol. 1999;40:21–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Taïeb, A., Picardo, M. (2019). Definitions and Classification. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Cham. https://doi.org/10.1007/978-3-319-62960-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-62960-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62958-2
Online ISBN: 978-3-319-62960-5
eBook Packages: MedicineMedicine (R0)